Summit Therapeutics Inc.

NasdaqGM:SMMT Stock Report

Market Cap: US$13.2b

Summit Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:SMMT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 24BuyUS$499,990Bhaskar AnandIndividual22,026US$22.70
11 Sep 24BuyUS$999,980Manmeet SoniIndividual44,052US$22.70
11 Sep 24BuyUS$75,499,996Robert DugganIndividual3,325,991US$22.70
11 Sep 24BuyUS$999,980Mahkam ZanganehIndividual44,052US$22.70
11 Sep 24BuyUS$999,980Caspian Capital, LPCompany44,052US$22.70
27 Mar 24BuyUS$411,094Mahkam ZanganehIndividual110,321US$3.75
26 Mar 24BuyUS$375,000Ankur DhingraIndividual100,000US$3.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SMMT?
Owner TypeNumber of SharesOwnership Percentage
General Public29,967,7874.06%
Public Companies31,523,5304.27%
Institutions84,971,13811.5%
Individual Insiders590,985,69180.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.2%.

Top Shareholders

Top 25 shareholders own 94.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
74.8%
Robert Duggan
551,695,096US$9.9b0.61%no data
4.85%
Mahkam Zanganeh
35,738,442US$638.6m0.89%no data
4.27%
Akeso, Inc.
31,523,530US$563.3m0%no data
3.31%
Baker Bros. Advisors LP
24,424,865US$436.5m5.18%4.56%
1.48%
The Vanguard Group, Inc.
10,946,536US$195.6m24.1%no data
1.13%
FMR LLC
8,303,062US$148.4m9.75%0.01%
1.1%
BlackRock, Inc.
8,094,685US$144.7m2.48%no data
0.74%
T. Rowe Price Group, Inc.
5,439,657US$97.2m166%0.01%
0.47%
State Street Global Advisors, Inc.
3,468,514US$62.0m-15.9%no data
0.42%
Geode Capital Management, LLC
3,099,808US$55.4m4.59%no data
0.41%
Manmeet Soni
3,020,242US$54.0m1.48%no data
0.19%
Charles Schwab Investment Management, Inc.
1,432,713US$25.6m53.3%no data
0.17%
Millennium Management LLC
1,222,346US$21.8m-37.1%0.02%
0.15%
abrdn plc
1,136,286US$20.3m0%0.02%
0.15%
Darwin Global Management Limited
1,084,880US$19.4m0%1.91%
0.14%
Rock Springs Capital Management LP
1,040,000US$18.6m0%0.66%
0.12%
Northern Trust Global Investments
857,327US$15.3m-10.7%no data
0.12%
Candriam, Société En Commandite Par Actions
850,403US$15.2m0%0.05%
0.094%
TD Asset Management, Inc.
694,722US$12.4m160%0.01%
0.094%
Pictet Asset Management Limited
691,404US$12.4m-2.43%0.01%
0.088%
Citadel Advisors LLC
650,833US$11.6m0%0.01%
0.074%
Morgan Stanley, Investment Banking and Brokerage Investments
546,725US$9.8m77.4%no data
0.058%
Balyasny Asset Management L.P.
431,176US$7.7m-57.3%0.02%
0.057%
First Trust Advisors LP
422,950US$7.6m-46.3%0.01%
0.055%
D. E. Shaw & Co., L.P.
402,167US$7.2m1,250%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Summit Therapeutics Inc. is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gary WaandersBryan Garnier & Co
Timothy ChiangBTIG
Arlinda LeeCanaccord Genuity